2022 Annual Meeting | N1 - Neuroscience in the Clinic: Neurobiology of Learning and Memory in 2022

Date Saturday 04/02/22

Time 12:15 PM - 02:15 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Joshua M. Shulman, MD, PhD, FAAN, Anna K. Gillespie, PhD

Topic(s) Aging, Dementia, and Behavioral Neurology, Movement Disorders

Learning Objectives Participants will become familiar with neural mechanisms underlying memory processes and be introduced to novel stimulation-based and neurofeedback approaches being developed to promote memory-related brain activity in Alzheimer's and other diseases of aging. We will discuss how such strategies for manipulating brain activity hold promise for therapeutic benefit as well as shedding light on fundamental mechanisms of cognitive processes.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
12:15 PM - 12:20 PM PDT	Introduction	Introduction Joshua M. Shulman, MD, PhD, FAAN
12:15 PM - 02:15 PM PDT	Speaker	walk in slides Joshua M. Shulman, MD, PhD, FAAN
12:20 PM - 12:50 PM PDT	Speaker	Invited Speaker Annabelle Singer, PhD
12:50 PM - 01:05 PM PDT	Abstract	001 - Feasibility, Safety, and Efficacy of Gamma Sensory Stimulation as a Novel Therapeutic Intervention for Alzheimer’s Disease Mihaly Hajos, PhD
01:05 PM - 01:35 PM PDT	Speaker	Invited Speaker Anna K. Gillespie, PhD
01:35 PM - 01:50 PM PDT	Abstract	002 - Left Rostral Prefrontal Connectivity Links Thalamic Stimulation to Changes in Abstraction Joey Hsu, MD
01:50 PM - 02:15 PM PDT	Discussion	Q&A and Discussion Joshua M. Shulman, MD, PhD, FAAN

Faculty Disclosures
Joshua M. Shulman, MD, PhD, FAAN	Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Anna K. Gillespie, PhD	The institution of Anna K. Gillespie, PhD has received research support from National Institute of Health. Anna K. Gillespie, PhD has received intellectual property interests from a discovery or technology relating to health care.
Annabelle Singer, PhD	An immediate family member of Annabelle Singer, PhD has received personal compensation for serving as an employee of OM1. An immediate family member of Annabelle Singer, PhD has received personal compensation for serving as an employee of Jvion. Annabelle Singer, PhD has stock in Cognito Therapeutic. The institution of Annabelle Singer, PhD has received research support from Cognito Therapeutics.
	No disclosure on file
Brent Vaughan	No disclosure on file
Jonathan T. Megerian, MD, PhD	Dr. Megerian has received personal compensation for serving as an employee of Yamo Pharmaceuticals. Dr. Megerian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics. Dr. Megerian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kuzani Pharmaceuticals. Dr. Megerian has received research support from Childrens Hospital of Orange County.
Zach Malchano	Mr. Malchano has received personal compensation for serving as an employee of Cognito Therapeutics, Inc.. Mr. Malchano has received stock or an ownership interest from Cognito Therapeutics.
Evan Hempel	No disclosure on file
Martin Williams	Martin Williams has received personal compensation for serving as an employee of Cognito Therapeutics. Martin Williams has received stock or an ownership interest from Cognito Therapeutics. Martin Williams has received intellectual property interests from a discovery or technology relating to health care.
Joey Hsu, MD	The institution of Mr. Hsu has received research support from Walter L. Copeland Fund of the Pittsburgh Foundation.
Suzanne Hendrix, PhD	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara.
Aylin Cimenser, PhD	Dr. Cimenser has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. An immediate family member of Dr. Cimenser has received personal compensation for serving as an employee of Boston Scientific Corporation. Dr. Cimenser has stock in Cognito Therapeutics Inc. An immediate family member of Dr. Cimenser has stock in Boston Scientific Corporation. Dr. Cimenser has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Cimenser has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Cimenser has received publishing royalties from a publication relating to health care.
Mihaly Hajos, PhD	Prof. Hajos has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. Prof. Hajos has stock in Cognito Therapeuitcs. Prof. Hajos has stock in Biogen. Prof. Hajos has stock in Pfizer. Prof. Hajos has received intellectual property interests from a discovery or technology relating to health care.
Dengyu Wang, MD	Mr. Wang has nothing to disclose.
Alyssa Boasso	No disclosure on file

��ɫ��

��ɫ��